Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

被引：1
|
作者：
Khan, Sana Irfan
Anwar, Muhammad Yasir
Rafae, Abdul
Khan, Anam
Khan, Atif Irfan
Aamir, Sobia
Batool, Syeda Sabeeka
Din, Asim Tameez Ud
Khan, Israr
Javaid, Anum
Qadeer, Haifza Abeera
Ahmed, Zahoor
Gul, Rohail
Aijaz, Zobia
Anwer, Faiz
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134986
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis
    Si, Tianyu
    Ma, Xiaolin
    Zhu, Wenwei
    Zhou, Yongming
    HEMATOLOGY, 2023, 28 (01)
  • [12] Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements
    Bertucci, Alexandre
    Bertucci, Francois
    Goncalves, Anthony
    CANCERS, 2023, 15 (05)
  • [13] Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Wu, Peng
    Su, Yi
    Guan, Xianghong
    Liu, Xiaowen
    Zhang, Jiankang
    Dong, Xiaowu
    Huang, Wenhai
    Hu, Yongzhou
    PLOS ONE, 2012, 7 (08):
  • [14] Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review
    Wen, Yanting
    Meng, Li
    Zhang, Xian
    Gao, Qian
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (09) : 849 - 856
  • [15] Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα
    Kim, Jinhee
    Hong, Seunghee
    Hong, Sungwoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 6977 - 6981
  • [16] Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors
    Pemberton, Nils
    Mogemark, Mickael
    Arlbrandt, Susanne
    Bold, Peter
    Cox, Rhona J.
    Gardelli, Cristina
    Holden, Neil S.
    Karabelas, Kostas
    Karlsson, Johan
    Lever, Sarah
    Li, Xueshan
    Lindrnark, Helena
    Norberg, Monica
    Perry, Matthew W. D.
    Petersen, Jens
    Blomqvist, Sandra Rodrigo
    Thomas, Matthew
    Tyrchan, Christian
    Eriksson, Annika Westin
    Zlatoidsky, Pavol
    Osterg, Linda
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5435 - 5441
  • [17] Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients
    Janku, Filip
    CANCER TREATMENT REVIEWS, 2017, 59 : 93 - 101
  • [18] Discovery of the Potent Phosphoinositide 3-Kinase δ (PI3 K δ) Inhibitors
    Lei, Tao
    Hong, Yongwei
    Chang, Xinyue
    Zhang, Zhimin
    Liu, Xingguo
    Hu, Miao
    Huang, Wenhai
    Yang, Haiyan
    CHEMISTRYSELECT, 2020, 5 (01): : 196 - 200
  • [19] Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function
    Fung-Leung, Wai-Ping
    CELLULAR SIGNALLING, 2011, 23 (04) : 603 - 608
  • [20] Approved and emerging PI3K inhibitors for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
    Kienle, Dirk L.
    Stilgenbauer, Stephan
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (08) : 917 - 929
12345